Company overview:
Brite is a comprehensive patient-facing platform designed to revolutionize hormone replacement therapy management. The app provides patients with an intuitive tool to track their hormone applications, access educational resources, manage refills, and stay connected with their healthcare providers. By simplifying the hormone therapy journey, Brite helps patients achieve better outcomes while reducing the administrative burden on medical practices.
Mission statement:
To empower patients on their hormone therapy journey by providing intuitive tracking tools, educational resources, and seamless provider communication—creating healthier patients for life.
Unique value-proposition:
Brite combines patient compliance tools with organic hormone delivery technology, offering a complete ecosystem that transforms how hormone therapy is managed. The platform features advanced decision support systems that help providers arrive at accurate dosages, while patients benefit from personalized reminders and self-guided resources. With the only patented 100% certified organic transdermal hormone base worldwide, Brite delivers superior hormone absorption without chemical solvents or additives.
Why we partner with them:
The Menopause Association partners with Brite because patient compliance is essential to successful hormone therapy outcomes. Many women struggle to maintain consistent hormone application routines, leading to suboptimal results and frustration. Brite addresses this challenge by providing personalized reminders, tracking tools, and educational content that keeps patients engaged and informed throughout their menopause journey. The platform’s focus on organic, solvent-free transdermal delivery aligns with our commitment to safe, effective, and patient-centered care. By connecting our members with Brite, we help ensure that women not only receive quality hormone therapy but also have the tools to maximize their treatment success.
Patients receive customized reminders for hormone applications on provider-set schedules. The app automatically adjusts when dosages change, ensuring patients always apply the correct amounts at the right times.
Comprehensive training videos, questionnaires, FAQs, and educational content guide patients through their hormone therapy journey, reducing the need for staff support and empowering informed decision-making.
Prescriptions last three months with easy in-app refill requests. Patients can manage their hormone supply without phone calls or paperwork, improving convenience and adherence.
Brite uses 100% certified organic oil bases with zero chemical solvents—the only worldwide patented organic transdermal hormone delivery system. Patients apply over a quart of hormone base annually; Brite ensures that base is pure and non-toxic.
Schedule a consultation to learn how Brite Live can transform your hormone therapy practice, reduce administrative burden, and improve patient outcomes.
Ask your healthcare provider about Brite Live or download the app from the App Store or Google Play to begin your guided hormone therapy journey.
Brite was founded by Dr. Daved Rosensweet, a physician who graduated from the University of Michigan Medical School in 1968 and has been in private practice since 1971. Named “One of the Biggest Names in Anti-Aging Medicine” by the American Academy of Anti-Aging Medicine (A4M), Dr. Rosensweet has treated more than 12,000 women using his methodology. He is the author of “Menopause and Natural Hormones” and “Happy Healthy Hormones: How to Thrive in Menopause,” and serves as co-chair of the Coalition to Protect Compounded Bioidentical Hormones. Brite represents over 15 years of innovation in BHRT patient care.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare provider before beginning any hormone therapy program.